Product Information
BUPRENORPHINE 15 MCG/HR PATCH is a generic product labeled by Alvogen Inc., priced at $45.9140 per EA under NDC 47781041904. Its NADAC has been published 190 times since Nov 9, 2022.
Strength
15 ug/h
Manufacturer
Alvogen Inc.NDC
47781041904
Classification
Generic
Dosage Form
PATCH, EXTENDED RELEASE
Route
TRANSDERMAL
Last Updated
6/17/2026
Active Ingredients
BUPRENORPHINEApproval Type
Generic (ANDA)
FDA Application
ANDA207490On Market Since
5/17/2022
Pharmacological Classes
Price Statistics
The NADAC for BUPRENORPHINE 15 MCG/HR PATCH has been published 190 times since Nov 9, 2022, and over the history we have for it it has declined 37.5%. The table below summarizes its recorded NADAC range and movement.
| Current price | $45.9140 per EA |
|---|---|
| All-time high | $95.2203 (Sep 13, 2023) |
| All-time low | $33.1572 (Jul 17, 2024) |
| 52-week high | $50.8017 |
| 52-week low | $44.1510 |
| Median price | $53.7231 |
| Average price | $56.7133 |
| Largest weekly change | +62.3% (Aug 21, 2024) |
| Weeks tracked | 190 |
| Tracking since | Nov 9, 2022 |
Generic Alternatives
The matcher finds 1 NADAC-published product sharing this drug's active ingredient, strength, and dosage form across 1 manufacturer (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of BUPRENORPHINE 15 MCG/HR PATCH?
The current National Average Drug Acquisition Cost (NADAC) for BUPRENORPHINE 15 MCG/HR PATCH, manufactured by Alvogen Inc., is $45.9140 per EA (NDC 47781041904), effective Jun 24, 2026.
How has the price of BUPRENORPHINE 15 MCG/HR PATCH changed over time?
Over the history we have for it, the NADAC for BUPRENORPHINE 15 MCG/HR PATCH has declined 37.5%. It has been tracked across 190 weekly CMS publications since Nov 9, 2022.
What are the highest and lowest recorded NADAC prices for BUPRENORPHINE 15 MCG/HR PATCH?
Since Nov 9, 2022, the NADAC for BUPRENORPHINE 15 MCG/HR PATCH has ranged from a low of $33.1572 (Jul 17, 2024) to a high of $95.2203 (Sep 13, 2023), with a median of $53.7231 per EA.
Are there cheaper alternatives to BUPRENORPHINE 15 MCG/HR PATCH?
1 NADAC-published product shares the same active ingredient, strength, and dosage form as BUPRENORPHINE 15 MCG/HR PATCH, but none are currently priced below it.
Who manufactures BUPRENORPHINE 15 MCG/HR PATCH?
BUPRENORPHINE 15 MCG/HR PATCH (NDC 47781041904) is labeled by Alvogen Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification